Use of proton pump inhibitors is associated with lower trabecular bone density in older individuals.

[1]  A. Szeląg,et al.  Overuse of proton pump inhibitors. , 2015, Polskie Archiwum Medycyny Wewnetrznej.

[2]  S. Bandinelli,et al.  Proton pump inhibitors and risk of 1-year mortality and rehospitalization in older patients discharged from acute care hospitals. , 2013, JAMA internal medicine.

[3]  H. Fujita,et al.  Age-Related Changes in Trabecular and Cortical Bone Microstructure , 2013, International journal of endocrinology.

[4]  Abdurrahman Sahin,et al.  Bone density in proton pump inhibitors users: a prospective study , 2013, Rheumatology International.

[5]  N. Abraham.  Proton pump inhibitors: potential adverse effects , 2012, Current opinion in gastroenterology.

[6]  Yu-Xiao Yang.  Chronic Proton Pump Inihibitor Therapy and Calcium Metabolism , 2012, Current Gastroenterology Reports.

[7]  S. Jamal,et al.  The Relationship Between Proton Pump Inhibitor Use and Longitudinal Change in Bone Mineral Density: A Population-Based From the Canadian Multicentre Osteoporosis Study (CaMos) , 2012, The American Journal of Gastroenterology.

[8]  N. Ahmed,et al.  Fracture Risk and Bone Mineral Density Reduction Associated with Proton Pump Inhibitors , 2012, Pharmacotherapy.

[9]  K. Devault,et al.  Systematic review: the use of proton pump inhibitors and increased susceptibility to enteric infection , 2012 .

[10]  R. Eastell,et al.  Proton pump inhibitor use and the antifracture efficacy of alendronate. , 2011, Archives of internal medicine.

[11]  D. Bauer,et al.  Proton pump inhibitors and risk of fractures: a meta-analysis of 11 international studies. , 2011, The American journal of medicine.

[12]  Alan S. Brown,et al.  ACCF/AHA 2011 expert consensus document on hypertension in the elderly: a report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents. , 2011, Circulation.

[13]  L. Køber,et al.  Proton pump inhibitor use and risk of adverse cardiovascular events in aspirin treated patients with first time myocardial infarction: nationwide propensity score matched study , 2011, BMJ : British Medical Journal.

[14]  A. Iorio,et al.  Prevalence and appropriateness of drug prescriptions for peptic ulcer and gastro-esophageal reflux disease in a cohort of hospitalized elderly. , 2011, European journal of internal medicine.

[15]  Y. Loke,et al.  Meta-analysis: risk of fractures with acid-suppressing medication. , 2011, Bone.

[16]  D. McCarthy.  Adverse effects of proton pump inhibitor drugs: clues and conclusions , 2010, Current opinion in gastroenterology.

[17]  G. Faulhaber,et al.  Could magnesium depletion play a role on fracture risk in PPI users? , 2010, Archives of internal medicine.

[18]  E. Kuipers,et al.  A case series of proton pump inhibitor-induced hypomagnesemia. , 2010, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[19]  U. Maggiore,et al.  Severe hypomagnesemia during long-term treatment with a proton pump inhibitor. , 2010, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[20]  J. Manson,et al.  Proton pump inhibitor use, hip fracture, and change in bone mineral density in postmenopausal women: results from the Women's Health Initiative. , 2010, Archives of internal medicine.

[21]  M. Howell,et al.  Iatrogenic gastric acid suppression and the risk of nosocomial Clostridium difficile infection. , 2010, Archives of internal medicine.

[22]  Amy Linsky,et al.  Proton pump inhibitors and risk for recurrent Clostridium difficile infection. , 2010, Archives of internal medicine.

[23]  M. Loeb,et al.  Meta‐analysis: proton pump inhibitor use and the risk of community‐acquired pneumonia , 2010, Alimentary pharmacology & therapeutics.

[24]  L. Lix,et al.  Proton-pump inhibitor use is not associated with osteoporosis or accelerated bone mineral density loss. , 2010, Gastroenterology.

[25]  M. Wallander,et al.  Acid-suppressive Drugs and Community-acquired Pneumonia , 2009, Epidemiology.

[26]  Deepak L. Bhatt,et al.  ACCF/ACG/AHA 2008 expert consensus document on reducing the gastrointestinal risks of antiplatelet therapy and NSAID use: a report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents. , 2008, Circulation.

[27]  D. Bauer,et al.  Acid-Suppressive Medications and Risk of Bone Loss and Fracture in Older Adults , 2008, Calcified Tissue International.

[28]  J. Gregor,et al.  Association between proton pump inhibitors and respiratory infections: a systematic review and meta-analysis of clinical trials. , 2008, Canadian journal of gastroenterology = Journal canadien de gastroenterologie.

[29]  T. Cundy,et al.  Severe hypomagnesaemia in long‐term users of proton‐pump inhibitors , 2008, Clinical endocrinology.

[30]  I. Forgacs,et al.  Overprescribing proton pump inhibitors , 2008, BMJ : British Medical Journal.

[31]  Luigi Ferrucci,et al.  Longitudinal Changes in BMD and Bone Geometry in a Population‐Based Study , 2007, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[32]  Sanjay Kaul,et al.  ACCF/ACG/AHA 2008 expert consensus document on reducing the gastrointestinal risks of antiplatelet therapy and NSAID use: a report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents. , 2008, Journal of the American College of Cardiology.

[33]  D. Reith,et al.  Continuation of Proton Pump Inhibitors from Hospital to Community , 2006, Pharmacy World and Science.

[34]  S. Bandinelli,et al.  Correlates of bone quality in older persons. , 2006, Bone.

[35]  D. Seripa,et al.  Clinical Features of Reflux Esophagitis in Older People: A Study of 840 Consecutive Patients , 2006, Journal of the American Geriatrics Society.

[36]  M. Saito,et al.  Degree of Mineralization-related Collagen Crosslinking in the Femoral Neck Cancellous Bone in Cases of Hip Fracture and Controls , 2006, Calcified Tissue International.

[37]  H. O'connor,et al.  Proton pump inhibitors: a survey of prescribing in an Irish general hospital , 2004, International journal of clinical practice.

[38]  J. M. Guralnik,et al.  Drug data coding and analysis in epidemiologic studies , 1994, European Journal of Epidemiology.

[39]  Miriam C J M Sturkenboom,et al.  Risk of community-acquired pneumonia and use of gastric acid-suppressive drugs. , 2004, JAMA.

[40]  J. Pérez-Castrillón,et al.  Homocysteine as a predictive factor for hip fracture in older persons. , 2004, The New England journal of medicine.

[41]  R. Valuck,et al.  A case-control study on adverse effects: H2 blocker or proton pump inhibitor use and risk of vitamin B12 deficiency in older adults. , 2004, Journal of clinical epidemiology.

[42]  N. M. Walker,et al.  An evaluation of the use of proton pump inhibitors , 2001, Pharmacy World and Science.

[43]  S. Bandinelli,et al.  Dietary intake estimated using different methods in two Italian older populations. , 2004, Archives of gerontology and geriatrics.

[44]  J. M. Guralnik,et al.  Aging bone in men and women: beyond changes in bone mineral density , 2003, Osteoporosis International.

[45]  E. Barrett-Connor,et al.  Identification and fracture outcomes of undiagnosed low bone mineral density in postmenopausal women: results from the National Osteoporosis Risk Assessment. , 2001, JAMA.

[46]  Luigi Ferrucci,et al.  Subsystems Contributing to the Decline in Ability to Walk: Bridging the Gap Between Epidemiology and Geriatric Practice in the InCHIANTI Study , 2000, Journal of the American Geriatrics Society.

[47]  U. Koch,et al.  Bone-muscle strength indices for the human lower leg. , 2000, Bone.

[48]  A. Vermeulen,et al.  A critical evaluation of simple methods for the estimation of free testosterone in serum. , 1999, The Journal of clinical endocrinology and metabolism.

[49]  S. Chapman,et al.  Why are patients prescribed proton pump inhibitors? Retrospective analysis of link between morbidity and prescribing in the General Practice Research Database , 1998, BMJ.

[50]  F Berrino,et al.  Relative validity and reproducibility of a food frequency dietary questionnaire for use in the Italian EPIC centres. , 1997, International journal of epidemiology.

[51]  A. Blum,et al.  Effects of omeprazole and lansoprazole on 24-hour intragastric pH in Helicobacter pylori-positive volunteers. , 1994, Scandinavian journal of gastroenterology.

[52]  P. Khazanie,et al.  Omeprazole Therapy Causes Malabsorption of Cyanocobalamin (Vitamin B12) , 1994, Annals of Internal Medicine.

[53]  R. Recker.  Calcium absorption and achlorhydria. , 2006, The New England journal of medicine.